Literature DB >> 23846589

The role of asbestos morphology on their cellular toxicity: an in vitro 3D Raman/Rayleigh imaging study.

Seydou Yao1, Yao Seydou1, Hsiang-Hsin Chen, Etienne Harte, Giancarlo Della Ventura, Cyril Petibois.   

Abstract

Amphiboles caused cohorts of deaths in exposed workers, leading to some of the largest class actions in the industry. Once inhaled, these inorganic fibers are thought to be both chemically and morphologically toxic, and their biopersistence in the lungs over decades lead to progressive pathologies, mesothelioma, and asbestosis. However, this exceptionally long chronicity for human pathologies suggests that chemical toxicity is certainly low, suggesting that morphological parameters could be more relevant in the pathology. Here, we developed a 3D Raman/optical imaging methodology in vitro to characterize both morphological and chemical parameters of cell/fiber interactions. We determined that lung cells could vesiculate amphiboles with length below 5 μm or could embed those not exceeding 15 μm in their fibrous extracellular matrix. Lung cells can thus develop defense strategies for handling the biopersistence of inorganic species, which may thus have major impact for biosafety issues related to nanomaterials.

Entities:  

Year:  2013        PMID: 23846589     DOI: 10.1007/s00216-013-7143-3

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  2 in total

1.  Unsaturated lipid bodies as a hallmark of inflammation studied by Raman 2D and 3D microscopy.

Authors:  K Czamara; K Majzner; A Selmi; M Baranska; Y Ozaki; A Kaczor
Journal:  Sci Rep       Date:  2017-01-18       Impact factor: 4.379

2.  3D chemical imaging of the brain using quantitative IR spectro-microscopy.

Authors:  Abiodun Ogunleke; Benoit Recur; Hugo Balacey; Hsiang-Hsin Chen; Maylis Delugin; Yeukuang Hwu; Sophie Javerzat; Cyril Petibois
Journal:  Chem Sci       Date:  2017-10-17       Impact factor: 9.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.